SyntBioLab Inc.
SyntBioLab Inc is biotechnology company based in Quebec that develops alternative antimicrobials against pathogenic bacteria affecting feedstock. We do believe that the era of using preventive antibiotics in feed is over and efficient alternatives are needed to prevent emergence of antibiotic resistant superbug. SyntBioLab uses bacteriophages to fight bacteria infecting livestock. The …
Profile
- Industry
- Feed, Fishery & aquaculture, Post-harvest & processing, Seeds & genetics, Veterinary
- Topics
- Livestock & poultry production/genetics, Animal feed & feed additives
- Role
- Research / RTO — “…It was a spinout from Laval University and received angel funding from Anges Quebec [5][3]. <details><summary>…”
- Why it is bioeconomy
- SyntBioLab Inc. is a biotechnology company that develops bacteriophage-based antimicrobial solutions as alternatives to antibiotics for the livestock and food-processing industries.
- Found via
- Intralytix; [Rubric] Canada · phages
Bio-solutions it supplies 0
Not yet cited as a supplier in a graded solution.
What they offer
This company does not publish its products or services — we find out through an introduction.
News & status 6
- 2025-10-16 Je suis tombé en bas de ma chaise ce matin en lisant cet article du Journal de Québec:SyntBioLab Inc. is mentioned as an example of a company capable of producing phages with the necessary standards for quality and quantity.
- 2025-07-22 "What if phages could help save tons of food every year?"SyntBioLab Inc. presents phages as a solution to control foodborne pathogens and extend shelf life, positioning themselves as the provider of a “THE solution” to reduce recalls and waste. They encourage contacting Julianne to learn more.
- 2026-02-17 Using biological processes to effectively target cancer and infectious disease with Esphera SynBio - Innovation FactoryEsphera SynBio is a Hamilton/Ottawa-based synthetic biology startup leveraging engineered exosomes to deliver cancer and infectious disease therapeutics directly inside the body, aiming for a Phase 1 cancer vaccine trial by 2027 and a $38M Series A in 2026, …
- 2025-04-24 Bacteriophages Antimicrobials Market: Industry Trends,The page is a market research PR about the Bacteriophages Antimicrobials market, produced by Worldwide Market Reports; it does not mention or provide any information about a company named SyntBioLab Inc. One or two sentences: There is no data on SyntBioLab …
- 2026-05-19 Ontario Investing $5 Million to Strengthen Province’s Position as a Global Leader in Life Sciences — OBIOSyntBioLab Inc. is not mentioned as one of the recipient companies in this Ontario Life Sciences Innovation Fund update; nine OBIO-affiliated companies are named, but SyntBioLab Inc. is not listed among them.
- 2026-09-17 Acceleration Consortium 2025SymBL Innovations (Symbiosis Biolabs) at the University of Toronto is developing a multi-microbe, waste-upcycling technology to convert organic waste into a palm kernel oil–alternative and other bioproducts, backed by the Acceleration Consortium with plans for …
Network: owners, partners, peers
Ownership & investors 3
| parent | Independent |
| investor | Anges Quebec |
| investor | Laval University |
Similar companies
Phagelux AgriHealth Inc. · SK8 Biotechnologies Inc. · Bio Agri Mix LP · Probiotech International Inc. · AmebaGone, Inc. · EVAH Corp. · NovoBind · Native Microbials, Inc.
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member